Myelodysplastic Syndrome: Rare Blood Disorder Linked To Benzene Exposure
Myelodysplastic syndrome is a condition in which the bone marrow in the body produces insufficient amounts of healthy blood cells which are needed to control various functions within the body. It is unknown exactly how many individuals in the United States have developed myelodysplastic syndrome as many cases of the condition go undiagnosed. Experts estimate that between 10,000 and 20,000 new cases of myelodysplastic syndrome occur each year.
Signs & Symptoms of Myelodysplastic syndrome (MDS):
Shortness of Breath
Decreased ability to fight infection, illness, or injury
Excessive or Uncontrolled bleeding
Reduction in the blood’s ability to clot
Although MDS can form inside the body without external causes, prolonged exposure to benzene—typically in industrial, workplace settings—is considered a contributing factor to developing the disease. Although the government has reduced the presence of benzene in industrial settings, it still remains in many industries. Benzene may be present in paint, paper, pesticides, leather, rubber, and plastics. Benzene is also used in oil refineries and in petroleum product manufacturing.